The novel therapy of this peptide represents a significant development in the handling of type 2 diabetes. Distinct from existing therapies, tirzepatide targets two pathways – the GLP-1 hormone and glucose-dependent https://tirzepatidepeptide685523.mpeblog.com/76220906/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment